He suggested the possible reversal of oxaliplatin resistance in CRC [53] by upregulating copper transporter 1 and downregulating ATPase copper transporting alpha (ATP7A) and ATPase copper transporting beta (ATP7B) [53]. The gene discussed is SLC31A1; the disease is colorectal carcinoma.